COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY

Por V. S. Dombrovskiy, G. R. Khachatryan
Publicado em 2017-03-01

Organizational structure and funding of health technology assessment agencies around the world

Por G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak
Publicado em 2019-07-01

The health technology assessment system in Australia

Por V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
Publicado em 2020-02-01

Health technology assessment and reimbursement of pharmaceuticals in Italy

Por F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
Publicado em 2019-07-01

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA

Por G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy
Publicado em 2016-04-01

Drug provision and health technology assessment in France

Por V. V. Omelyanovskiy, A. V. Nikitina, V. A. Lemeshko, G. R. Khachatryan
Publicado em 2020-04-01

MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN

Por V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan
Publicado em 2015-03-01

Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan

Por T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova
Publicado em 2019-05-01

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS

Por V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko
Publicado em 2017-08-01

Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871

Por V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
Publicado em 2020-08-01

Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy

Por V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov
Publicado em 2021-04-01

Review of the current approaches to the assessment of the drug innovative potential worldwide

Por N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
Publicado em 2017-11-01